In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results of the CREST-2 trials and Research Summary: nej.md/3LK9kst
Presented at #ISC26, the CREST-2 trial results showed neither the addition of CAS nor CEA to IMM demonstrated cognitive benefit compared to IMM alone, including in patients with worse baseline cognition.
Here is @tmadsenemβs take on the results.
It's a New Year and SVIN has a New, Exciting Grand Rounds Lecture lined up for you!
π CREST-2 Trial: Rethinking Stroke Prevention in Asymptomatic Carotid Stenosis
π January 27, 2026 β 12:00 PM CT
π€ Presenter, Principal Investigator CREST 2 : James F. Meschia, M.D.
Register here: zurl.co/YUEJu#SVIN#GrandRounds#CREST2Trial
AAN members, join Drs. James F. Meschia and Brajesh K. Lal on the AAN Section Spotlight webinar (@AANmember) this Wednesday from 5-6PM Eastern! ποΈ
Click on the link to login to your AAN account and register for the webinar: learning.aan.com/webinars/88β¦
Join Drs. Brajesh K. Lal and Thomas G. Brott on the Frank J. Veith International Society's webinar (@FJVIS1) this Wednesday from 12-1:30PM Eastern! ποΈ
Click on the link to register: us06web.zoom.us/webinar/regiβ¦
James Meschia, MD is the recipient of the 2025 Innovation Award!
This award recognizes groundbreaking vision and advancements shaping the future of neurovascular care. Congratulations, Dr. Meschia!
Learn more at zurl.co/koC6e#SVIN#SVIN25#SVINAnnualMeeting#SVINAwards#InnovationAward
CREST 2 RESULTS PRESENTED AT THE 52nd Annual VEITHsymposium BY DR. THOMAS BROTT - Listen to what Dr. Brott and our faculty experts have to say: Favoring stenting β¦.
youtu.be/PPwK-s8cCV4
π¨Post Session Interview with Dr. Meschia discussing the Primary results of the CREST-2 trialΒ presented during our Late Breaking abstracts yesterday!
#SVIN25
Presented at #SVIN25:
CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: nej.md/3LK9kst
Editorial: Managing Asymptomatic Carotid Stenosis nej.md/482XjG1@svinsociety
ALT The Society of Vascular and Interventional Neurology 2025 Annual Meeting
Original Article | NOV 21, 2025 | NEJM.org
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
Figure 2A. Primary-Outcome Analysis.
The NEJM signature sits at the bottom.
Congratulations to Diana C. De Los Santos at Kaiser Permanente Los Angeles Medical Center (@KPLACounty) for being CREST-2's June Coordinator of the Month! ππ·
#CarotidStenosis#Stroke#Research
Congratulations to Dr. Navdeep Sangha at Kaiser Permanente Los Angeles Medical Center (@KPLACounty) for being CREST-2's June Investigator of the Month! ππ·
#CarotidStenosis#Stroke#Research
Congratulations to Caitlan LeMatty at the Medical University of South Carolina (@MUSChealth) for being CREST-2's April Coordinator of the Month! ππ·
#CarotidStenosis#Stroke#Research
Congratulations to Dr. Christine Holmstedt at the Medical University of South Carolina (@MUSChealth) for being CREST-2's April Investigator of the Month! ππ·
#CarotidStenosis#Stroke#Research